Can Jardiance (Empagliflozin) cause itching?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Jardiance Cause Itching?

Yes, Jardiance (empagliflozin) can cause itching, primarily as a symptom of genital mycotic infections (vaginal or penile yeast infections), which are among the most common adverse reactions to this medication. 1

Primary Mechanism of Itching with Jardiance

The itching associated with Jardiance occurs predominantly through two pathways:

  • Genital mycotic infections are explicitly listed in the FDA label as common adverse reactions, with vaginal itching being a specific symptom of vaginal yeast infections in women 1
  • Penile yeast infections (balanitis or balanoposthitis) in men can cause itching, redness, or swelling of the penis, particularly in uncircumcised males 1

Clinical Presentation

When itching occurs with Jardiance, look for these specific patterns:

  • In women: Vaginal itching accompanied by white or yellowish vaginal discharge (may be lumpy or cottage cheese-like) and vaginal odor 1
  • In men: Itching of the penis with rash, redness, swelling, foul-smelling discharge, or pain in the skin around the penis 1
  • Timing: These mycotic infections typically develop after starting the medication, as SGLT2 inhibitors increase glucose in the urine, creating a favorable environment for yeast growth 2

Management Approach

For mild genital itching from suspected yeast infection, initiate over-the-counter antifungal treatment immediately while continuing Jardiance, as the FDA label specifically advises discussing treatment options with patients. 1

  • Apply topical antifungal agents (such as clotrimazole or miconazole) to affected genital areas as first-line treatment 1
  • Consider oral fluconazole 150 mg as a single dose for more severe or recurrent vaginal yeast infections 1
  • Maintain adequate genital hygiene and keep the area dry to prevent recurrence 1

When to Consider Drug Discontinuation

  • Hypersensitivity reactions: If itching is accompanied by urticaria or angioedema, discontinue Jardiance immediately, as serious hypersensitivity reactions have been reported 1
  • Recurrent infections: Chronic and recurrent genital mycotic infections may require reassessment of continued Jardiance use, particularly in patients with predisposing factors 1
  • Generalized pruritus without rash: If itching is widespread and not localized to genital areas, conduct a comprehensive evaluation for drug-induced pruritus, including liver function tests and renal function, as drug-induced itching can occur without visible skin lesions 3, 4

Differential Considerations

If itching persists or presents atypically:

  • Rule out urinary tract infection, which is also common with Jardiance and may cause perineal discomfort that could be mistaken for itching 1
  • Assess for cholestatic liver disease if generalized itching develops, as drug-induced cholestasis can cause pruritus 3
  • Consider trial cessation if the risk-benefit analysis supports it and itching significantly impacts quality of life 3

Patient Counseling Points

  • Inform patients that genital yeast infections with associated itching are expected common side effects of Jardiance 1
  • Advise patients to report symptoms early so treatment can be initiated promptly without necessarily discontinuing the medication 1
  • Emphasize that most cases respond well to antifungal treatment and do not require stopping Jardiance 1
  • Instruct patients to seek immediate medical attention if they develop signs of serious hypersensitivity (facial swelling, difficulty breathing, widespread rash) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-Induced Itch Management.

Current problems in dermatology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.